Interleukin 3D structures
From Proteopedia
(Difference between revisions)
| Line 17: | Line 17: | ||
**[[3ltq]] - hIL-1 β residues 117-269 <BR /> | **[[3ltq]] - hIL-1 β residues 117-269 <BR /> | ||
**[[3pok]] - hIL-1 β residues 117-269 (mutant) <BR /> | **[[3pok]] - hIL-1 β residues 117-269 (mutant) <BR /> | ||
| + | **[[6y8i]], [[6y8m]] - hIL-1 β residues 117-269 + pyridine derivative<BR /> | ||
**[[1itb]] - hIL-1 β + IL-1 receptor 1 extracellular domain<BR /> | **[[1itb]] - hIL-1 β + IL-1 receptor 1 extracellular domain<BR /> | ||
**[[3o4o]] - hIL-1 β + IL-1 receptor 2 + IL-1 receptor accessory protein<BR /> | **[[3o4o]] - hIL-1 β + IL-1 receptor 2 + IL-1 receptor accessory protein<BR /> | ||
| Line 47: | Line 48: | ||
**[[1jli]] – hIL-3 (mutant) – NMR<BR /> | **[[1jli]] – hIL-3 (mutant) – NMR<BR /> | ||
| + | **[[6nmy]] – hIL-3 + IL-3 receptor α + cytokine receptor common subunit β<BR /> | ||
**[[5uv8]], [[5uwc]] – hIL-3 (mutant) + IL-3 receptor α<BR /> | **[[5uv8]], [[5uwc]] – hIL-3 (mutant) + IL-3 receptor α<BR /> | ||
**[[2l3o]] – mIL-3 residues 33-156 (mutant) - NMR | **[[2l3o]] – mIL-3 residues 33-156 (mutant) - NMR | ||
| Line 88: | Line 90: | ||
*IL-8 | *IL-8 | ||
| - | **[[ | + | **[[6n2u]] – hIL-8 <BR /> |
**[[1il8]], [[2il8]], [[5wdz]] – hIL-8 - NMR<BR /> | **[[1il8]], [[2il8]], [[5wdz]] – hIL-8 - NMR<BR /> | ||
**[[1qe6]], [[1icw]] – hIL-8 (mutant) <BR /> | **[[1qe6]], [[1icw]] – hIL-8 (mutant) <BR /> | ||
**[[1ikl]], [[1ikm]] - hIL-8 (mutant) - NMR<BR /> | **[[1ikl]], [[1ikm]] - hIL-8 (mutant) - NMR<BR /> | ||
| + | **[[3il8]], [[5d14]], [[4xdx]] – hIL-8 residues 28-99<BR /> | ||
**[[1rod]] - hIL-8/melanoma growth stimulating protein – NMR<br /> | **[[1rod]] - hIL-8/melanoma growth stimulating protein – NMR<br /> | ||
**[[1ilp]], [[1ilq]] - hIL-8 + IL-8 receptor peptide | **[[1ilp]], [[1ilq]] - hIL-8 + IL-8 receptor peptide | ||
| Line 123: | Line 126: | ||
**[[5mxa]] - hIL-12 β + hIL- 23 α<br /> | **[[5mxa]] - hIL-12 β + hIL- 23 α<br /> | ||
**[[5mj3]], [[5mj4]] - hIL-12 β + hIL-23 α + alphabody MB3<br /> | **[[5mj3]], [[5mj4]] - hIL-12 β + hIL-23 α + alphabody MB3<br /> | ||
| - | **[[3qwr]] - hIL-12 β + hIL- 23 α + adnectin | + | **[[3qwr]] - hIL-12 β + hIL- 23 α + adnectin<br /> |
| + | **[[6uib]] - hIL-12 β + hIL- 23 α + peptide<br /> | ||
| + | **[[6sff]] - mIL-12 β <br /> | ||
*IL-13 | *IL-13 | ||
| Line 154: | Line 159: | ||
**[[5vb9]] - hIL-17A + peptide inhibitor<BR /> | **[[5vb9]] - hIL-17A + peptide inhibitor<BR /> | ||
**[[5hi5]], [[5hi4]], [[5hi3]], [[5hhx]], [[5hhv]] - hIL-17A + peptide inhibitor + antibody<BR /> | **[[5hi5]], [[5hi4]], [[5hi3]], [[5hhx]], [[5hhv]] - hIL-17A + peptide inhibitor + antibody<BR /> | ||
| - | **[[1jpy]] – hIL-17F<BR /> | + | **[[1jpy]], [[6hgo]] – hIL-17F<BR /> |
| - | **[[3jvf]] - hIL-17F + IL-17 receptor α | + | **[[6ppg]] – hIL-17F + antibody<BR /> |
| + | **[[3jvf]], [[6hg4]], [[6hg9]] - hIL-17F + IL-17 receptor α | ||
*IL-18 (Interferon-γ inducing factor) | *IL-18 (Interferon-γ inducing factor) | ||
| Line 225: | Line 231: | ||
*IL-36 | *IL-36 | ||
| + | **[[6hpi]] - hIL-36 α - NMR<br /> | ||
**[[4ize]] - hIL-36 γ<br /> | **[[4ize]] - hIL-36 γ<br /> | ||
| - | **[[6p9e]] - hIL-36 | + | **[[6p9e]] - hIL-36 γ + antagonist<br /> |
*IL-37 | *IL-37 | ||
Revision as of 07:27, 26 August 2020
3D structures of interleukin
Updated on 26-August-2020
